BioCentury
ARTICLE | Distillery Therapeutics

Neurology

June 28, 2018 5:50 PM UTC

In vitro and mouse studies identified triazole sulfonamide-based Nav1.7 inhibitors that could help treat pain. Chemical synthesis of triazole sulfonamide-analogs and screening in cell-based binding as...

BCIQ Target Profiles

Nav1.7 (SCN9A)